Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Lupus Sci Med. 2021 Jan;8(1). doi: 10.1136/lupus-2020-000453.
We hypothesised that intracellular homocysteine and homocysteine metabolite levels in patients with SLE are disproportionately elevated compared with the levels seen in healthy subjects and that they are independently associated with coronary plaque in SLE.
A liquid chromatography-tandem mass spectrometry absolute quantification assay was used for the determination of six analytes in both plasma and peripheral blood mononuclear cells (PBMCs): homocysteine (Hcy), S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), methionine (Met), cystathionine (Cysta) and 5-methyltetrahydrofolate (5m-THF). We then compared intracellular (PBMC) and extracellular (plasma) Hcy and Hcy metabolite (SAM, SAH, Met, Cysta and 5m-THF) concentrations in 10 patients with SLE and in 10 age, sex and ethnicity matched controls. Subjects with a history of diabetes mellitus, cardiovascular disease, hypertension, alcohol consumption in excess of 3 units per day, anaemia, renal insufficiency (serum creatinine >1.5 mg/dL) and pregnancy were excluded. All patients with SLE had two coronary CT angiography studies as screening for occult coronary atherosclerotic disease.
Plasma from patients with SLE had higher levels of Hcy (p<0.0001), SAH (p<0.05), SAM (p<0.001) and lower levels of Met (p<0.05) and Cysta (p<0.001) compared with controls. PBMC intracellular concentrations from patients with SLE had higher levels of Cysta (p<0.05), SAH (p<0.05), SAM (p<0.001) and lower levels of 5m-THF (p<0.001). Plasma SAH showed a positive correlation with total coronary plaque, calcified plaque and non-calcified plaque (p<0.05).
Intracellular concentrations of Hcy metabolites were significantly different between patients with SLE and controls, despite similar intracellular Hcy levels. Plasma SAH was positively correlated with total coronary plaque, calcified plaque and non-calcified plaque.
我们假设,与健康受试者相比,SLE 患者的细胞内同型半胱氨酸和同型半胱氨酸代谢物水平不成比例地升高,并且它们与 SLE 患者的冠状动脉斑块独立相关。
使用液相色谱-串联质谱绝对定量测定法测定血浆和外周血单核细胞(PBMC)中的六种分析物:同型半胱氨酸(Hcy)、S-腺苷甲硫氨酸(SAM)、S-腺苷同型半胱氨酸(SAH)、蛋氨酸(Met)、胱硫醚(Cysta)和 5-甲基四氢叶酸(5m-THF)。然后,我们比较了 10 例 SLE 患者和 10 名年龄、性别和种族匹配的对照者的细胞内(PBMC)和细胞外(血浆)Hcy 和 Hcy 代谢物(SAM、SAH、Met、Cysta 和 5m-THF)浓度。排除有糖尿病、心血管疾病、高血压、每天饮酒超过 3 单位、贫血、肾功能不全(血清肌酐>1.5mg/dL)和妊娠病史的患者。所有 SLE 患者均进行了两次冠状动脉 CT 血管造影检查,以筛查隐匿性冠状动脉粥样硬化性疾病。
与对照组相比,SLE 患者的血浆 Hcy(p<0.0001)、SAH(p<0.05)、SAM(p<0.001)水平升高,Met(p<0.05)和 Cysta(p<0.001)水平降低。SLE 患者的 PBMC 细胞内浓度中 Cysta(p<0.05)、SAH(p<0.05)、SAM(p<0.001)水平升高,5m-THF(p<0.001)水平降低。血浆 SAH 与总冠状动脉斑块、钙化斑块和非钙化斑块呈正相关(p<0.05)。
尽管细胞内 Hcy 水平相似,但 SLE 患者和对照组之间 Hcy 代谢物的细胞内浓度有显著差异。血浆 SAH 与总冠状动脉斑块、钙化斑块和非钙化斑块呈正相关。